The introduction of human papillomavirus (HPV) vaccination in China aims to prevent HPV
infection in all women. The issues that China might face include high cost of vaccines made …

HPV-related diseases represent a major cause of morbidity and mortality, although effective
HPV vaccines are available, potentially allowing for the elimination of these malignancies …

This article presents the World Health Organization's (WHO) recommendations on the use of
human papillomavirus (HPV) vaccines excerpted from the WHO position paper on Human …

Cancer is an important cause of premature death in low-and middle-income countries
(LMIC). Two preventive tools are available that have the potential together to sharply …

Background We aimed to review the burden and the potential impact of human
papillomavirus (HPV) vaccines on HPV-related diseases in the Republic of Korea and to …

At the beginning of October one of the trials of vaccines against human papillomavirus
(HPV) infection, the primary risk factor for cervical cancer, announced an encouraging result …

On Nov 26, 2021, the Ministry of Health, Labour, and Welfare of Japan officially issued an
announcement to resume active recommendations of the human papillomavirus (HPV) …

Prophylactic vaccines for human papillomavirus (HPV) are being introduced in many
countries for the prevention of cervical cancer, the second most important cause of cancer …

Persistent human papillomavirus infection is the central cause of cervical cancer, the leading
cause of cancer death among women worldwide. Clear evidence from both randomized …

We analysed country recommendations and funding plans finalized through January 2008
for the inclusion of quadrivalent and bivalent human papillomavirus (HPV) vaccines in …